Bibliografia sul Bioterrorismo virale e sulle contromisure governative e sanitarie

1. Henderson, D. A. The looming threat of bioterrorism. Science 1999, 283, 1279–1282.
2. Monto, A. The role of antivirals in the control of influenza. Vaccine 2003, 21, 1796–1800.
3. Bray, M; Roy, C. J. Antiviral prophylaxis of smallpox. J. Antimicrob. Chemother. 2004, 54,
1–5.
4. www.niaid.nih.gov/biodefense.
5. Eitzen, E. M. Use of biological weapons. In Textbook of Military Medicine, Office of the
Surgeon General, Department of the Army, Washington, DC, 1997, pp. 437–450.
6. Eitzen, E. M.; Takafuji, E. Historical overview of biological warfare. In Textbook of
Military Medicine, Office of the Surgeon General, Department of the Army, Washington,
DC, 1997, pp. 415–436.
7. Rotz, L.; Khan, A.; Lillibridge, S. R.; Ostroff, S. M.; Hughes, J. M. Public health
assessment of potential biological terrorism agents. Emerging Infect. Dis. 2002, 8,
225–229.
8. Henderson, D; Inglesby, T.; Bartlett, J. G.; Ascher, M. S.; Eitzen, E.; Jahrling, P. B.; Hauer,
J.; Layton, M; McDade, J.; Osterholm, M. T.; O’Toole, T.; Parker, G.; Perl, T.; Russell, P.
K.; Tonat, K. Smallpox as a biological weapon: medical and public health management.
JAMA 1999, 281, 2127–2137.
9. Jahrling, P. B. Viral hemorrhagic fevers. In Textbook of Military Medicine, Office of the
Surgeon General, Department of the Army, Washington, DC, 1997, pp. 591–602.
10. Borio, L.; Inglesby, T.; Peters, C. J.; Schmaljohn, A. L.; Hughes, J. M.; Jahrling, P. B.;
Ksiazek, T.; Johnson, K. M.; Meyerhoff, A.; O’Toole, T.; Ascher, M. S.; Bartlett, J.;
Breman, J. G.; Eitzen, E. M. Jr.; Hamburg, M.; Hauer, J.; Henderson, D. A.; Johnson, R. T.;
Kwik, G.; Layton, M.; Lillibridge, S.; Nabel, G. J.; Osterholm, M. T.; Perl, T. M.; Russell,
P.; Tonat, K.; Working Group on Civilian Biodefense. Hemorrhagic fever viruses
as biological weapons—medical and public health management. JAMA 2002, 287,
2391–2405.
11. Franz, D.; Jahrling, P. B; McClain, D. J.; Hoover, D. L.; Byrne, W. R.; Pavlin, J. A.;
Christopher, G.W.; Cieslak, T. J.; Friedlander, A. M.; Eitzen, E. M. Jr. Clinical recognition
and management of patients exposed to biological warfare agents. JAMA 1997, 278,
399–411.

12. Smith, J.; Davis, K. Viral encephalitides. In Textbook of Military Medicine, Office of the
Surgeon General, Department of the Army, Washington, DC, 1997, pp. 561–589.
13. Alibek, J.; Handelman, S. Biohazard. Random House, New York, 1999.
14. Bray, M.; Buller, R. M. L. Looking back at smallpox. Clin. Infect. Dis. 2004, 38, 882–890.
15. Basler, C. F.; Wang, X.; Muhlberger, E.; Volchkov, V.; Paragas, J.; Klenk, H. D.; Garcia-
Sastre, A.; Palese, P. The Ebola virus VP35 protein functions as a type I IFN antagonist.
Proc. Natl. Acad. Sci. USA 2000, 97, 12289–12294.
16. Basler, C. F.; Mikulasova, A.; Martinez-Sobrido, L.; Paragas, J.; Muhlberger, E.; Bray, M.;
Klenk, H. D.; Palese, P.; Garcia-Sastre, A. The Ebola virus VP35 protein inhibits
activation of interferon regulatory factor 3. J. Virol. 2003, 77, 7945–7956.
17. Bray, M.; Mahanty, S. Ebola hemorrhagic fever and septic shock. J. Infect. Dis. 2003, 188,
1613–1617.
18. Geisbert, T. W.; Hensley, L. E.; Larsen, T.; Young, H. A.; Reed, D. S.; Geisbert, J. B.;
Scott, D. P.; Kagan, E.; Jahrling, P. B.; Davis, K. J. Pathogenesis of Ebola hemorrhagic
fever in cynomolgus macaques. Am. J. Pathol. 2003, 163, 2347–2370.
19. Mahanty, S.; Bray, M. Pathogenesis of filoviral hemorrhagic fevers. Lancet Infect. Dis.
2004, 4, 487–498.
20. Geisbert, T. W.; Young, H. A.; Jahrling, P. B.; Davis, K. J.; Kagan. E.; Hensley,
E. Mechanism underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression
of tissue factor in primate monocytes/macrophages. J. Infect. Dis. 2003, 188,
1618–1629.
21. Van Dissel, J. T.; van Langevelde, P.; Westendorp, R. G.; Kwappenberg, K.; Frolich, M.
Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998, 351,
950–953.
22. Hill, A. V. The genomics and genetics of human infectious disease susceptibility. Annu.
Rev. Genomics Hum. Genet. 2001, 2, 373–400.
23. Westendorp, R. G.; Langermans, J. A.; Huizinga, T. W.; Verweij, C. L.; Sturk, A. Genetic
influence on cytokine production in meningococcal disease. Lancet 1997, 349,
1912–1917.
24. Baize, S.; Leroy, E. M; Georges, A. J.; Georges-Courbot, M. C.; Capron, M.; Bedjabaga,
I.; Lansoud-Soukate, J.; Mavoungou, E. Inflammatory responses in Ebola virus-infected
patients. Clin. Exp. Immunol. 2002, 128, 163–168.